FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 69975

News■ Unclear/unknown

Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 21:51 UTC
LAST UPDATE2026-10-07 21:51 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

FDA expanded indication widens the treatable patient pool for this vascular device, but the company is private.

Private medtech milestone, no public-market read-through
CATALYST TO WATCH

Commercial rollout and reimbursement decisions

MAIN RISK

Private company, no investable ticker

FULL DISPATCH

ALISO VIEJO, Calif., Oct. 7, 2026 /PRNewswire/ -- Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S. FDA has granted an expanded indication for its LOBO® Vascular Occlusion System. The expanded indication extends the...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-07 21:51 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.